P2RX7 and neuroblastoma: We previously identified Sp1 as the main nuclear factor involved in controlling P2rx7 gene expression in N2a neuroblastoma cells and here, blocking Sp1-dependent transcription with mithramycin A significantly reduced but did not abolish the expression of P2RX7 in BCI-treated cells.